3VHV | Transcription Inhibitor | date | Sep 07, 2011 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Mineralocorticoid Receptor Ligand-Binding Domain With Non-St Antagonist | ||||||||||||||
authors | S.Sogabe, N.Habuka | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Mineralocorticoid Receptor Chain: A Fragment: Ligand-Binding Domain, Unp Residues 727-984 Synonym: Mr, Nuclear Receptor Subfamily 3 Group C Member 2 Engineered: Yes Mutation: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Nr3c2, Mcr, Mlr Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_vector_type: Plasmid | ||||||||||||||
symmetry | Space Group: P 32 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.35 Å | ||||||||||||
ligand | EDO, K, LD1, LD2 | enzyme |
| ||||||||||||
note | 3VHV is a representative structure | ||||||||||||||
Primary reference | Identification of Benzoxazin-3-one Derivatives as Novel, Potent, and Selective Nonsteroidal Mineralocorticoid Receptor Antagonists., Hasui T, Matsunaga N, Ora T, Ohyabu N, Nishigaki N, Imura Y, Igata Y, Matsui H, Motoyaji T, Tanaka T, Habuka N, Sogabe S, Ono M, Siedem CS, Tang TP, Gauthier C, De Meese LA, Boyd SA, Fukumoto S, J Med Chem. 2011 Dec 22;54(24):8616-31. Epub 2011 Nov 29. PMID:22074142 |
Data retrieval |
View 3VHV in 3D |
Visual 3D analysis of 3VHV |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3VHV |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |